|
Volumn 13, Issue 11, 2002, Pages 1261-1262
|
The current status of clinical gene therapy
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
DNA VACCINE;
FIBROBLAST GROWTH FACTOR 1;
RECOMBINANT DNA;
VASCULOTROPIN;
ADENOVIRUS;
ANGIOGENESIS;
ARTHRITIS;
CANCER IMMUNOTHERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
EYE DISEASE;
FOOD AND DRUG ADMINISTRATION;
GENE DELIVERY SYSTEM;
GENE TARGETING;
GENE THERAPY;
GENETIC DISORDER;
HEMOPHILIA;
HISTORY OF MEDICINE;
HUMAN;
INFECTION;
LICENSING;
MENTAL DISEASE;
PERIPHERAL VASCULAR DISEASE;
PREDICTION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VACCINATION;
VIRUS REPLICATION;
CLINICAL TRIALS;
FORECASTING;
GENE TARGETING;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC DISEASES, INBORN;
GENETIC VECTORS;
HUMANS;
NEOPLASMS;
ADENOVIRIDAE;
|
EID: 0036374980
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/104303402760128496 Document Type: Conference Paper |
Times cited : (24)
|
References (0)
|